Neuroblasztóma: vizsgálatok itt: Egyesült Államok
60 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleMolecular Analysis Of Solid Tumors
- Where
- Memphis
- Életkor
- Up to 25 év
- People
- 1000
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT01050296 - No phaseTaking peopleA Natural History Study of Children and Adults With Olfactory Neuroblastoma
- Where
- Bethesda
- Életkor
- 3 év to 120 év
- People
- 525
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04755205 - 2. fázisTaking peopleNaxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma
- Where
- Hershey
- Életkor
- 1 év to 30 év
- People
- 101
- Run by
- Giselle Sholler
See details and how to joinNCT07932808 - No phaseTaking peopleResource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Where
- Atlanta, Aurora, Boston, Cincinnati, Dallas, Hartford, New York, Philadelphia, Seattle
- Életkor
- Up to 17 év
- People
- 84
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06831552 - 1/2. fázisTaking peopleSilmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Where
- Birmingham, Charleston, Dallas, Detroit, Gainesville, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Louisville, Miami, Milwaukee, Nashville, Oakland, Orlando, Phoenix, Providence, Richmond, Sacramento, Salt Lake City, San Diego, St Louis, St. Petersburg, Tampa
- Életkor
- Up to 30 év
- People
- 104 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06541262 - 2. fázisTaking peopleA Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Where
- New York
- People
- 286
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04936529 - 2. fázisTaking peopleA Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 16
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07527169 - 1. fázisTaking peopleA First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06041516 - 2. fázisTaking peopleA Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057948 - 1/2. fázisTaking peopleTesting the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
- Where
- Chicago, Columbia, New York, Oakland
- Életkor
- 1 év to 30 év
- People
- 76
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07437963 - No phaseTaking peopleProspective Comprehensive Molecular Analysis of Endocrine Neoplasms
- Where
- Bethesda
- Életkor
- 4 év and over
- People
- 2415
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01005654 - 2. fázisTaking peopleEnasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06176989 - 1. fázisTaking peoplePEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
- Where
- Charlotte, Gainesville, Hershey
- Életkor
- 1 év to 30 év
- People
- 24
- Run by
- University of Florida
See details and how to joinNCT04837547 - 2/3. fázisTaking peopleA Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
- Where
- Aurora, Chicago, Dallas, Durham, Minneapolis, Philadelphia, San Francisco, The Bronx
- Életkor
- 18 hónap to 18 év
- People
- 144 worldwide
- Run by
- Renaissance Pharma Ltd.
See details and how to joinNCT07549321 · EU 2025-524397-42-00 - 3. fázisTaking peopleDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Where
- Akron, Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boston, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Detroit, Downey, Duarte, Durham, El Paso, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tacoma, The Bronx, Toledo, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winston-Salem
- Életkor
- Up to 30 év
- People
- 478 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06172296 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1. fázisTaking peopleAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Where
- Madison
- Életkor
- 7 hónap to 21 év
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT02508038 - 2. fázisTaking peopleMyeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Where
- Minneapolis
- Életkor
- Up to 30 év
- People
- 12
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT02605421 - No phaseTaking peopleInternational PPB/DICER1 Registry
- Where
- Minneapolis
- Életkor
- 0 Minutes to 100 év
- People
- 3400
- Run by
- Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT03382158 - 1. fázisTaking peoplePhase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- Where
- Bethesda
- Életkor
- 3 év to 35 év
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06995872 - No phaseTaking peopleComprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- Where
- Bethesda, Charlotte, New York, Orange, Washington D.C.
- Életkor
- 4 hét and over
- People
- 6035
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01109394 - 1. fázisTaking peopleGPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Where
- Palo Alto
- Életkor
- 1 év to 30 év
- People
- 18
- Run by
- Stanford University
See details and how to joinNCT07087002 - 1. fázisTaking peoplePhase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Where
- Cincinnati, Dallas, Lubbock, Milwaukee, Oklahoma City
- Életkor
- 12 hónap to 20 év
- People
- 30
- Run by
- South Plains Oncology Consortium
See details and how to joinNCT02013336 - 1. fázisTaking people[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06479811 - 1/2. fázisTaking peoplePEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Where
- Boston, Houston, Los Angeles, Philadelphia, Salt Lake City, San Francisco
- Életkor
- 1 év to 30 év
- People
- 59
- Run by
- Theodore Laetsch
See details and how to joinNCT06721689